Definitive Contract 75F40120C00024
Award Date 3/16/20
Potential Completion Date 3/16/23
Potential Value $814K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $120,500.00 firm-fixed-price purchase order contract to Unchained Labs, LLC (doing business as Optim) for its UNCLE PLATFORM product. This contract was set aside for small businesses. Unchained Labs is a biotechnology research company that provides scientific instrumentation, equipment, and services to federal agencies such as HHS, the Department of Veterans Affairs, and the Department of Agriculture...
- This is a $229,200.00 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Unchained Labs, LLC, doing business as Optim, a for-profit biotechnology manufacturer. The contract, which has a set-aside for small businesses, is for the delivery of the "FFPHUNK PROTEIN PLATFORM" to support the FDA's "HUNK PROTEIN STABILITY PLATFORM" program. Unchained Labs specializes in advanced scientific instrumentation, equipment, and services for government...
- The U.S. Food and Drug Administration (FDA) awarded a firm fixed-price purchase order contract to Unchained Labs, LLC (doing business as Optim), a for-profit biotechnology research company based in Pleasanton, California. The $158,060.00 contract is for the purchase of a Protein Chemical Stability Analyzer with accessories, training, and four optional years of service agreement. This sole-source contract was not set aside. Unchained Labs, which specializes in advanced scientific...
- This federal contract award from the Food and Drug Administration (FDA) was granted to Unchained Labs, LLC, doing business as Optim, to provide a Fluorescence Protein Thermal Stability Measuring Instrument (Unit). The $151,375.00 firm fixed-price purchase order did not have a set-aside designation. Unchained Labs is a biotechnology research company that specializes in advanced scientific instrumentation, equipment, and services for government research programs, particularly supporting efforts in...
- The U.S. Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price Purchase Order contract to Unchained Labs, LLC, a biotechnology research company doing business as Optim, for the provision of software applications. The contract has a potential value of $257,449.00 and a completion date of July 26, 2021. The contract was not set aside for a specific business size or type. Unchained Labs, LLC has previously provided scientific...
- The Department of Health and Human Services Food and Drug Administration awarded a $370,516.75 firm fixed price purchase order to Unchained Labs, LLC doing business as Optim for the 'BIG TUNA' AUTOMATED BIOLOGICAL FORMULATION AND BUFFER EXCHANGE SYSTEM. Place of performance will be in Silver Spring, Maryland, running from April 13, 2020 to May 21, 2025. This purchase order fulfills the stated need under a solicitation seeking a King Fisher APEX96 Deep Well Instrument for DNA Lysate processing,...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Unchained Labs, LLC, a biotechnology research company operating under the trade name Optim. The contract is for the delivery of a laboratory instrument with a potential value of $178,259.50 and a completion date of May 24, 2024. Unchained Labs is a for-profit organization and manufacturer that has received numerous prime federal...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Unchained Labs, LLC, a biotechnology research company doing business as Optim. The $131,041.00 contract has a completion date of February 8, 2024 and does not have a set-aside designation. Unchained Labs provides scientific instrumentation, equipment, and services to support research efforts in areas such as...
- The Food and Drug Administration awarded a purchase order to Unchained Labs, LLC for a Stunner AF fluorescence analytical platform with UV/Vis, Dynamic Light Scattering, and Rotating Angle Dynamic Light Scattering capabilities on September 10, 2026, with a ceiling value of $175,974.36. No set-aside was used. The system will be installed at FDA's Center for Biologics Evaluation and Research in Silver Spring, Maryland and is configured to characterize Adeno-Associated Virus vectors and Lipid...
- The Department of Health and Human Services Food and Drug Administration awarded a purchase order contract valued at one hundred fifty-two thousand eight hundred ninety-seven dollars and ninety cents ($152,897.90) to Biolog, Inc. of Hayward, California. The contract is for the delivery of Biolog OminiLog Plus ID Systems as described in solicitation FDA-CSS-1228215. The period of performance is from July 21, 2020 through December 29, 2025. This small business set-aside contract will provide the...
The Department of Health and Human Services Food and Drug Administration awarded a definitive contract valued at $814,426.75 to Unchained Labs, LLC doing business as Optim. The contract is for the delivery of an Automated Biologic Formulation Analyzer over a three-year period of performance ending March 2023. The place of performance is Silver Spring, Maryland. This firm fixed price contract has a total small business set aside designation. Optim will provide the FDA with the requested biologic analysis equipment to support the agency's regulatory programs. No major subcontractors or additional context were indicated in the available information.
Generated 12/25/23, 3:56 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Exercise an Option | $55.3k | 2/11/22 | |
| P00002 | Other Administrative Action | $0 | 5/25/21 | |
| P00001 | Exercise an Option | $37.3k | 12/31/20 | |
| Not listed | Not listed | $684.5k | 3/16/20 |